Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Braskem (BAK) Cash & Current Investments (2016 - 2025)

Braskem has reported Cash & Current Investments over the past 17 years, most recently at $2.0 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 22.22% year-over-year to $2.0 billion; the TTM value through Dec 2025 reached $2.0 billion, down 22.22%, while the annual FY2025 figure was $2.0 billion, 22.22% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $2.0 billion at Braskem, up from $2.0 billion in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $2.9 billion in Q4 2023 and troughed at $78.1 million in Q3 2021.
  • A 5-year average of $2.1 billion and a median of $2.4 billion in 2022 define the central range for Cash & Current Investments.
  • Biggest five-year swings in Cash & Current Investments: crashed 39.3% in 2021 and later skyrocketed 53.59% in 2022.
  • Year by year, Cash & Current Investments stood at $1.6 billion in 2021, then soared by 53.59% to $2.4 billion in 2022, then increased by 20.58% to $2.9 billion in 2023, then dropped by 10.44% to $2.6 billion in 2024, then fell by 22.22% to $2.0 billion in 2025.
  • Business Quant data shows Cash & Current Investments for BAK at $2.0 billion in Q4 2025, $2.0 billion in Q1 2025, and $2.6 billion in Q4 2024.